A Naturally Processed Peptide Presented by HLA-A*0201 Is Expressed at Low Abundance and Recognized by an Alloreactive CD8+ Cytotoxic T Cell with Apparent High Affinity

Journal of Immunology

Volumn 158, Issue 12, 1997, Pages 5797-5804

  Wang, Wei ^a   Gulden, Pamela H ^b   Pierce, Richard A ^a   Shabanowitz, Jeffrey A ^b   Man, Stephen T ^a,c   Hunt, Donald F ^a,b   Engelhard, Victor H ^a,d  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c CARDIFF UNIVERSITY   (United Kingdom)

^d UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; EPITOPE; HLA A ANTIGEN; PEPTIDE;

ARTICLE; CELL CLONE; CYTOTOXIC T LYMPHOCYTE; HUMAN; IMMUNOLOGY;

CLONE CELLS; EPITOPES; HLA-A ANTIGENS; HUMANS; ISOANTIGENS; PEPTIDES; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0031570538     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Hogquist, K. A., S. C. Jameson, W. R. Heath, J. L. Howard, M. J. Bevan, and F. R. Carbone. 1994. T cell receptor antagonist peptides induce positive selection. Cell 76:17.
2. Ashton-Rickardt, P. G., A. Bandeira, J. R. Delaney, L. Van Kaer, H.-P. Pircher, R. M. Zinkernagel, and S. Tonegawa. 1994. Evidence for a differential avidity model of T cell selection in the thymus. Cell 76:651.
3. Sherman, L. A., and S. Chattopadhyay. 1993. The molecular basis of allorecognition. Annu. Rev. Immunol. 11:385.
4. Heath, W. R., K. P. Kane, M. F. Mescher, and L. A. Sherman. 1991. Alloreactive T cells discriminate among a diverse set of endogenous peptides. Proc. Natl. Acad. Sci. USA 88:5101.
5. Rotzschke, O., K. Falk, S. Faath, and H. G. Rammensee. 1991. On the nature of peptides involved in T cell alloreactivity. J. Exp. Med. 174:1059.
6. Crumpacker, D. B., J. Alexander, P. Cresswell, and V. H. Engelhard. 1992. Role of endogenous peptides in murine allogeneic cytotoxic T cell responses assessed using transfectants of the antigen processing mutant 174xCEM.T2. J. Immunol. 148:3004.
7. Man, S., R. D. Salter, and V. H. Engelhard. 1992. Role of endogenous peptide in human alloreactive cytotoxic T cell responses. Int. Immunol. 4:367.
8. Engelhard, V. H. 1994. Structure of peptides associated with class I and class II MHC molecules. Annu. Rev. Immunol. 12:181.
9. Bevan, M. J. 1984. High determinant density may explain the phenomenon of alloreactivity. Immunol. Today 5:128.
10. Elliot, T. J., and H. N. Eisen. 1990. Cytotoxic T lymphocytes recognize a reconstituted class I histocompatibility antigen (HLA-A2) as an allogeneic target molecule. Proc. Natl. Acad Sci. USA 87:5213.
11. Mullbacher, A., A. B. Hill, R. V. Blanden, W. B. Cowden, N. J. King, and R. T. Hla. 1991. Alloreactive cytotoxic T cells recognize MHC class I antigen without peptide specificity. J. Immunol. 147:1765.
12. Henderson, R. A., A. L. Cox, K. Sakaguchi, E. Appella, J. Shabanowitz, D. F. Hunt, and V. H. Engelhard. 1993. Direct identification of an endogenous peptide recognized by multiple HLA-A2.1 specific cytotoxic T cells. Proc. Natl. Acad. Sci. USA 90:10275.
13. + cytotoxic T lymphocytes in association with class I MHC protein. Cell 69:989.
14. Tsomides, T. J., A. Aldovini, R. P. Johnson, B. D. Walker, R. A. Young, and H. N. Eisen. 1994. Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1. J. Exp. Med. 180:1283.
15. Hunt, D. F., R. A. Henderson, J. Shabanowitz, K. Sakaguchi, H. Michel, N. Sevilir, A. Cox, E. Appella, and V. H. Engelhard. 1992. Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. Science 255:1261.
16. Cox, A. L., J. Skipper, Y. Chen, R. A. Henderson, T. L. Darrow, J. Shabanowitz, V. H. Engelhard, D. F. Hunt, and C. L. Slingluff. 1994. Identification of a peptide recognized by live melanoma-specific human cytotoxic T cell lines. Science 264: 716.
17. Ruppert, J., J. Sidney, E. Celis, R. T. Kubo, H. M. Grey, and A. Sette. 1993. Prominent role of secondary anchor residues in peplide binding to A2.1 molecules. Cell 74:929.
18. Sette, A., J. Sidney, M. F. Del Guercio, S. Southwood, J. Ruppert, C. Dahlberg, H. M. Grey, and R. T. Kubo. 1994. Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays. Mol. Immunol. 31:813.
19. Chen, Y., J. Sidney, S. Southwood, A. L. Cox, K. Sakaguchi, R. Henderson, E. Appella, D. F. Hunt, A. Sette, and V. H. Engelhard. 1994. Naturally processed peptides longer than nine amino acid residues bind to the class I MHC molecule HLA-A2.1 with high affinity and in different conformations. J. Immunol. 152: 2874.
20. den Haan, J. M., N. E. Sherman, E. Blokland, E. Huczko, F. Koning, J. W. Drijfhout, J. Skipper, J. Shabanowitz, D. F. Hunt, V. H. Engelhard, and E. Goulmy. 1995. Identification of a graft versus host disease-associated human minor histocompatibility antigen. Science 268:1476.
21. b antigen. Cell 79:649.
22. + T cells can recognize unusual, rare, and unique processed peplide/MHC complexes. J. Immunol. 157:4464.
23. Poindexter, N. J., B. Naziruddin, D. W. McCourt, and T. Mohanakumar. 1995. Isolation of a kidney-specific peptide recognized by alloreactive HLA-A3-restricted human CTL. J. Immunol. 154:3880.
24. - strains. Proc. Natl. Acad. Sci. USA 91:11482.
25. Lauzurica, P., R. Bragado, D. Lopez, B. Galocha, and J. A. Lopez de Castro. 1992. Asymmetric selection of T cell antigen receptor alpha- and beta-chains in HLA-B27 allorcactivity. J. Immunol. 148:3624.
26. Geiger, M. J., J. Gorski, and D. D. Eckels. 1991. T cell receptor gene segment utilization by HLA-DR1-alloreactive T cell clones. J. Immunol. 147:2082.
27. Miceli, M. C., and O. J. Finn. 1989. T cell receptor beta-chain selection in human allograft rejection. J. Immunol. 142:81.
28. Teitell, M., H. Holcombe, H. Cheroutre, C. J. Aldrich, I. Stroynowski, J. Forman, and M. Kronenberg. 1993. The α3 domain of the Qa-2 molecule is defective for CD8 binding and cytotoxic T lymphocyte activation. J. Exp. Med. 178:2139.
29. + T lymphocytes in TAP1 and beta 2-microglobulin mutant mice. Eur. J. Immunol. 25:174.
30. + T cells. Immunity 3:79.
31. Kageyama, S., T. J. Tsomides, Y. Sykulev, and H. N. Eisen. 1995. Variations in the number of peptide-MHC class I complexes required to activate cytotoxic T cell responses. J. Immunol. 154:567.
32. Loftus, D. J., Y. Chen, D. G. Covell, V. H. Engelhard, and E. Appella. 1997. Differential contact of disparate class I/peptide complexes as the basis for epitope cross-recognition by a single TCR. J. Immunol. 158:3651.
33. Garcia, K. C., M. Degano, R. L. Stanfield, A. Brunmark, M. R. Jackson, P. A. Peterson, L. Teyton, and I. A. Wilson. 1996. An αβ T cell receptor structure at 2.5 A and its orientation in the TCR-MHC complex. Science 274:209.
34. Wang, W., L. R. Meadows, J. M. den Haan, N. E. Sherman, Y. Chen, E. Blokland, J. Shabanowitz, A. Agulnik, R. C. Hendrickson, C. E. Bishop, D. F. Hunt, E. Goulmy, and V. H. Engelhard. 1995. Human H-Y: a male-specific histocompalibility antigen derived from the SMCY protein. Science 269:1588.
35. Wallny, H. J., K. Deres, S. Faath, G. Jung, A. Van Pel, T. Boon, and H. G. Rummensee. 1992. Identification and quantification of a naturally presented peptide as recognized by cytotoxic T lymphocytes specific for an immunogenic tumor variant. Int. Immunol. 4:1085.
36. Falk, K., O. Rotzschke, K. Deres, J. Metzger, G. Jung, and H. G. Rammensee. 1991. Identification of naturally processed viral nonapeptides allows their quantification in infected cells and suggests an allele-specific T cell epitope forecast. J. Exp. Med. 174:425.
37. Rotzschke, O., K. Falk, S. Stevanovic, G. Jung, P. Walden, and H. G. Rammensee. 1991. Exact prediction of a natural T cell epitope. Eur. J. Immunol. 21:2891.